Blokhina A, Ershova A, Kiseleva A, Sotnikova E, Zharikova A, Zaicenoka M
    
    
    PLoS One. 2024; 19(12):e0315693.
  
  
    PMID: 39705280
    
          PMC: 11661581.
    
          DOI: 10.1371/journal.pone.0315693.
      
 
                                  
  
    Fahed A, Natarajan P
    
    
    Atherosclerosis. 2023; 386:117356.
  
  
    PMID: 37931336
    
          PMC: 10842813.
    
          DOI: 10.1016/j.atherosclerosis.2023.117356.
      
 
                                  
  
    Caffarelli C, Santamaria F, Piro E, Basilicata S, DAntonio L, Tchana B
    
    
    Ital J Pediatr. 2023; 49(1):115.
  
  
    PMID: 37679850
    
          PMC: 10485969.
    
          DOI: 10.1186/s13052-023-01522-8.
      
 
                                  
  
    Kamal A, Kanchau J, Shahuri N, Mohamed-Yassin M, Baharudin N, Abdul Razak S
    
    
    Am J Case Rep. 2023; 24:e939489.
  
  
    PMID: 37185657
    
          PMC: 10152508.
    
          DOI: 10.12659/AJCR.939489.
      
 
                                  
  
    Reijman M, Defesche J, Wiegman A
    
    
    Curr Opin Lipidol. 2023; 34(6):287-295.
  
  
    PMID: 36752612
    
          PMC: 10624405.
    
          DOI: 10.1097/MOL.0000000000000863.
      
 
                              
              
                              
                                      
  The Clinical Importance of Differentiating Monogenic Familial Hypercholesterolemia from Polygenic Hypercholesterolemia.
  
    Tandirerung F
    
    
    Curr Cardiol Rep. 2022; 24(11):1669-1677.
  
  
    PMID: 36083530
    
          PMC: 9729145.
    
          DOI: 10.1007/s11886-022-01783-5.
      
 
                                          
                                                          
  Detecting Familial hypercholesterolemia in children and adolescents: potential and challenges.
  
    Banderali G, Capra M, Biasucci G, Stracquadaino R, Viggiano C, Pederiva C
    
    
    Ital J Pediatr. 2022; 48(1):115.
  
  
    PMID: 35840982
    
          PMC: 9287900.
    
          DOI: 10.1186/s13052-022-01257-y.
      
 
                                          
                                                          
  The Role of Registers in Increasing Knowledge and Improving Management of Children and Adolescents Affected by Familial Hypercholesterolemia: the LIPIGEN Pediatric Group.
  
    Gazzotti M, Casula M, Bertolini S, Capra M, Olmastroni E, Catapano A
    
    
    Front Genet. 2022; 13:912510.
  
  
    PMID: 35795214
    
          PMC: 9251337.
    
          DOI: 10.3389/fgene.2022.912510.
      
 
                                          
                                                          
  Genetic Polymorphisms in a Familial Hypercholesterolemia Population from North-Eastern Europe.
  
    Mastaleru A, Cojocariu S, Oancea A, Leon Constantin M, Roca M, Zota I
    
    
    J Pers Med. 2022; 12(3).
  
  
    PMID: 35330428
    
          PMC: 8949493.
    
          DOI: 10.3390/jpm12030429.
      
 
                                          
                                                          
  Clinical characterization of familial hypercholesterolemia due to an amish founder mutation in Apolipoprotein B.
  
    Williams K, Horst M, Young M, Pascua C, Puffenberger E, Brigatti K
    
    
    BMC Cardiovasc Disord. 2022; 22(1):109.
  
  
    PMID: 35300601
    
          PMC: 8928591.
    
          DOI: 10.1186/s12872-022-02539-3.
      
 
                                          
                                                          
  PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on diagnosis and therapy of lipid disorders in Poland 2021.
  
    Banach M, Burchardt P, Chlebus K, Dobrowolski P, Dudek D, Dyrbus K
    
    
    Arch Med Sci. 2021; 17(6):1447-1547.
  
  
    PMID: 34900032
    
          PMC: 8641518.
    
          DOI: 10.5114/aoms/141941.
      
 
                                          
                                                          
  Pharmacogenomics Variability of Lipid-Lowering Therapies in Familial Hypercholesterolemia.
  
    Hindi N, Alenbawi J, Nemer G
    
    
    J Pers Med. 2021; 11(9).
  
  
    PMID: 34575654
    
          PMC: 8468752.
    
          DOI: 10.3390/jpm11090877.
      
 
                                          
                                                          
  The Digenic Causality in Familial Hypercholesterolemia: Revising the Genotype-Phenotype Correlations of the Disease.
  
    Kamar A, Khalil A, Nemer G
    
    
    Front Genet. 2021; 11:572045.
  
  
    PMID: 33519890
    
          PMC: 7844333.
    
          DOI: 10.3389/fgene.2020.572045.
      
 
                                          
                                                          
  Prevalence of cardiovascular events in genetically confirmed versus unconfirmed familial hypercholesterolaemia.
  
    Khan T, Breen J, Neves E, Grocott-Mason R, Barbir M
    
    
    Glob Cardiol Sci Pract. 2021; 2020(2):e202024.
  
  
    PMID: 33426041
    
          PMC: 7768534.
    
          DOI: 10.21542/gcsp.2020.24.
      
 
                                          
                                                          
  Screening of common genetic variants in the APOB gene related to familial hypercholesterolemia in a Saudi population: A case-control study.
  
    Batais M, Almigbal T, Shaik N, Alharbi F, Alharbi K, Ali Khan I
    
    
    Medicine (Baltimore). 2019; 98(4):e14247.
  
  
    PMID: 30681615
    
          PMC: 6358331.
    
          DOI: 10.1097/MD.0000000000014247.
      
 
                                          
                                                          
  Premature Valvular Heart Disease in Homozygous Familial Hypercholesterolemia.
  
    Fahed A, Shibbani K, Andary R, Arabi M, Habib R, Nguyen D
    
    
    Cholesterol. 2017; 2017:3685265.
  
  
    PMID: 28761763
    
          PMC: 5518507.
    
          DOI: 10.1155/2017/3685265.
      
 
                                          
                                                          
  A Genome-Wide Association Study Identifies the Genomic Region Associated with Shell Color in Yesso Scallop, Patinopecten yessoensis.
  
    Zhao L, Li Y, Li Y, Yu J, Liao H, Wang S
    
    
    Mar Biotechnol (NY). 2017; 19(3):301-309.
  
  
    PMID: 28527015
    
    
          DOI: 10.1007/s10126-017-9751-y.
      
 
                                          
                                                          
  Genetic testing of familial hypercholesterolemia in a real clinical setting.
  
    Vohnout B, Gabcova D, Huckova M, Klimes I, Gasperikova D, Raslova K
    
    
    Wien Klin Wochenschr. 2016; 128(23-24):916-921.
  
  
    PMID: 27542166
    
    
          DOI: 10.1007/s00508-016-1053-2.
      
 
                                          
                                                          
  Variable expressivity and co-occurrence of LDLR and LDLRAP1 mutations in familial hypercholesterolemia: failure of the dominant and recessive dichotomy.
  
    Fahed A, Khalaf R, Salloum R, Andary R, Safa R, El-Rassy I
    
    
    Mol Genet Genomic Med. 2016; 4(3):283-91.
  
  
    PMID: 27247956
    
          PMC: 4867562.
    
          DOI: 10.1002/mgg3.203.
      
 
                                          
                                                          
  The genetics and screening of familial hypercholesterolaemia.
  
    Henderson R, OKane M, McGilligan V, Watterson S
    
    
    J Biomed Sci. 2016; 23:39.
  
  
    PMID: 27084339
    
          PMC: 4833930.
    
          DOI: 10.1186/s12929-016-0256-1.